← Evidence map

ArticleLeukemia2021

miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma.

Marco Rossi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

37 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it

The trial

NCT0721432460 enrolled2025
Full record →Abstract, authors, funding and every citing paper · PMID 32632096